Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.

Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden on Tuesday, increasing access to the widely popular medications to millions of adults with obesity in the U.S., though the plan would likely face opposition under President-elect Donald Trump's second administration.

Doctors recommend that people on weight-loss drugs try to avoid foods that are slathered in butter or sugar. So opt for the green beans with almond slivers over the dense green bean casserole and perhaps consider the homemade cranberry sauce over the canned variety.

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump administration.

Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.